Mephentermine: Rediscovering its biology and use, misuse and their implications;Mefentermina: Redescobrindo sua biologia, uso, abuso e suas implicações

Revista Brasileira de Psiquiatria

Volumn 33, Issue 1, 2011, Pages 98-99

  de Oliveira, Matheus Fernandes ^a,b   de Sousa, Henrique Faria ^a   Lima, Murilo Costa Duarte ^a   de Oliveira, João Ricardo Mendes ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; MEPHENTERMINE; METHAMPHETAMINE; PHENTERMINE; POTEMAX; POTENAY; PROMETHAZINE; UNCLASSIFIED DRUG;

ANEMIA; CARDIOVASCULAR DISEASE; DRUG DEPENDENCE; FATIGUE; HEALTH PROGRAM; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; LETTER; MALNUTRITION; NONHUMAN; PSYCHOSIS; RECOMMENDED DRUG DOSE; SUBSTANCE ABUSE; SUDDEN DEATH;

EID: 79956333657     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462011000100019     Document Type: Letter

References (5)

1. Docherty JR. Pharmacology of stimulants phohibited by the World Anti-Doping Agency (WADA). Br J Pharmacol. 2008;154(3):606-22.
2. Kansal A, Mohta M, Sethi AK, Tyagi A, Kumar P. Randomised trial of intravenous infusion of ephedrine or mephentermine for management of hypotension during spinal anaesthesia for Caesarean section. Anaesthesia. 2005;60(1):28-34.
3. Basu D, Nebhinani N. Mephentermine dependence without psychosis. Indian J Med Sci. 2009;63(3):117-9.
4. Sousa HF, Oliveira MF, Costa Lima MD, Oliveira JR. Mephentermine dependence without psychosis: a Brazilian case report. Addiction. 2010;105(6):1129-30.
5. Oliveira JR. Much ado about cognitive enhancement. Nature. 2009;457(7229):532.